NCT05848882

Brief Summary

The goal of this clinical trial si to compare two removable devices used to treat the transversal discrepancies in growing patients. The main questions it aims to answer are:

  • the efficacy of the two devices in the palatal expansion
  • the neuromuscolar effects developed on the stomatognatic system Participants will be instructed in the use and maintenance of the devices and will be checked every 15-30 days for one year.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 16, 2023

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 18, 2023

Completed
8 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 26, 2023

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

April 27, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 8, 2023

Completed
Last Updated

May 12, 2023

Status Verified

May 1, 2023

Enrollment Period

1 month

First QC Date

April 27, 2023

Last Update Submit

May 11, 2023

Conditions

Keywords

elastodontic devicegrowing patientstransversal palatal discrepancies

Outcome Measures

Primary Outcomes (1)

  • Palatal first premolars width

    To compare the palatal first premolars width in three times

    12 months

Study Arms (2)

Elastodontic removable device

EXPERIMENTAL

Patients in this group will be treat with an elastodontic device adapted to the patient according to the shape of the dental arches. This device is similar to a mouthguard and embraces both dental arches. This appliance is worn overnight and the patient will be checked every month. The distance between the palatal cusps of the first upper premolars will be taken at T0( before the start of the therapy), at T1 (after six months)and at T2 (after one month). All the dental recors will be taken by the same operator with an intraoral scanner 3D.

Device: Elastodontic Device

Schwarz removable device

EXPERIMENTAL

Patients in this group will be treat with a Schwarz removable device constructed individually by the dental technician.This device has a resin baseplate with an activation screw in the center and Adams hooks on the upper first molars and it works by turning the expansion screw in the center of the palate one-quarter turn, once or twice a month by the ortodontist. This appliance is worn overnight and some hours during the day (totally 16 hours).The distance between the palatal cusps of the first upper premolars will be taken at T0( before the start of the therapy), at T1 (after six months)and at T2 (after one month). All the dental recors will be taken by the same operator with an intraoral scanner 3D.

Device: Elastodontic Device

Interventions

Removable device that embraces two dental archs

Elastodontic removable deviceSchwarz removable device

Eligibility Criteria

Age9 Years - 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • skeletal class I relationship, molar class I relationship; complete eruption of upper first premolars ; presence of unilateral or bilateral cross bite (falling within grade 3 IOTN index)

You may not qualify if:

  • IOTN index \>4; presence of temporomandibular disorders, epilepsy, systemic diseases, periodontal disease, absence of written informed consent signed by parents/legal guardians

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dipartimento MeSVA

L’Aquila, Aq, 67100, Italy

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 27, 2023

First Posted

May 8, 2023

Study Start

March 16, 2023

Primary Completion

April 18, 2023

Study Completion

April 26, 2023

Last Updated

May 12, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations